Jupiter Neurosciences Inc (JUNS)

May 04, 2026

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit - TradingView

May 04, 2026

Apr 27, 2026

[EFFECT] JUPITER NEUROSCIENCES, INC. SEC Filing - Stock Titan

Apr 27, 2026

Apr 24, 2026

JUPITER NEUROSCIENCES INC (JUNS) Fundamental Analysis & Valuation - ChartMill

Apr 24, 2026

Apr 21, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 21, 2026

Apr 21, 2026

Jupiter: Rise in AUMs Driven by CCLA Acquisition Completion, Net Inflows - Moomoo

Apr 21, 2026

Apr 21, 2026

Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 - WFXG

Apr 21, 2026

Apr 20, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 20, 2026

Apr 15, 2026

Jupiter Neurosciences (NASDAQ: JUNS) files shelf to sell up to $100M in securities - Stock Titan

Apr 15, 2026

Apr 14, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Apr 14, 2026

Apr 13, 2026

Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14 - The Globe and Mail

Apr 13, 2026

Apr 13, 2026

Nasdaq hosts Jupiter Neurosciences CEO at April 14 investor conference - Stock Titan

Apr 13, 2026

Apr 13, 2026

Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS - The Joplin Globe

Apr 13, 2026

Apr 13, 2026

Growth Review: Will Jupiter Neurosciences Inc benefit from rising consumer demand2026 Update & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Winners Losers: What are analysts price targets for EMP PRAEarnings Risk Summary & Weekly Breakout Watchlists - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS - Caledonian Record

Apr 12, 2026

Apr 12, 2026

JUNS PE Ratio & Valuation, Is JUNS Overvalued - Intellectia AI

Apr 12, 2026

Apr 10, 2026

Forecast Cut: What analysts say about Jupiter Neurosciences Inc stockWeekly Profit Report & Safe Capital Growth Plans - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Swing Trade: Can Avis Budget Group Inc sustain earnings growth2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn

Apr 10, 2026

Apr 08, 2026

Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board - The National Law Review

Apr 08, 2026

Apr 08, 2026

Investment Review: Will Jupiter Neurosciences Inc benefit from rising consumer demandMarket Movers & Safe Entry Point Identification - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Jupiter Neurosciences adds advisors for consumer product line By Investing.com - Investing.com Australia

Apr 07, 2026

Apr 07, 2026

Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia Advisory Board - Bitget

Apr 07, 2026

Apr 07, 2026

Jupiter Neurosciences adds advisors for consumer product expansion By Investing.com - Investing.com Canada

Apr 07, 2026

Apr 07, 2026

Jupiter Neurosciences adds advisors for consumer product expansion - Investing.com

Apr 07, 2026

Apr 07, 2026

Jupiter Neurosciences adds advisors for consumer product line - Investing.com

Apr 07, 2026

Apr 06, 2026

Breakout Move: Is Jupiter Neurosciences Inc forming a bullish divergence2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

JUNS SEC FilingsJUPITER NEUROSCIENCES, INC. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026

Apr 04, 2026

How does earnings affect Jupiter Neurosciences (JUNS) Stock | Price at $0.40, Up 4.18%Stock Market Community - Newser

Apr 04, 2026

Apr 03, 2026

JUNS Stock Analysis: Jupiter Neurosciences Inc. Biotech 2.9% Dip Update at $0.37 - UBND thành phố Hải Phòng

Apr 03, 2026

Apr 02, 2026

Jupiter Neurosciences, Inc. Advances JOTROL™ Resveratrol Platform for Neuroinflammation Treatments and Launches Nugevia Longevity Supplements 69 70 73 108 - Minichart

Apr 02, 2026

Apr 01, 2026

Jupiter Neurosciences Delays Annual 10-K Filing - TipRanks

Apr 01, 2026

Apr 01, 2026

Jupiter Neurosciences 2025 10-K: $21.8K Revenue, $0.00 EPS (net loss $8.64M) - TradingView — Track All Markets

Apr 01, 2026

Apr 01, 2026

Jupiter Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Jupiter Neurosciences (JUNS) flags going concern risk and expands JOTROL, Nugevia strategy - stocktitan.net

Apr 01, 2026

Apr 01, 2026

[NT 10-K] JUPITER NEUROSCIENCES, INC. SEC Filing - stocktitan.net

Apr 01, 2026

Apr 01, 2026

Breakout Move: Will Jupiter Neurosciences Inc benefit from geopolitical trends2026 Levels & Daily Momentum Trading Reports - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

North Country Limousine Opens 2026 Wine Tour Reservations for Long Island’s North Fork - weeklyvoice.com

Mar 31, 2026

Mar 31, 2026

Jupiter Neurosciences to Present at Emerging Growth Conference on April 2 - The Norfolk Daily News

Mar 31, 2026

Mar 31, 2026

Investors can hear Jupiter Neurosciences outline progress Apr. 2 - Stock Titan

Mar 31, 2026

Mar 28, 2026

Will The GEO Group Inc outperform during market ralliesPortfolio Value Summary & Weekly Return Optimization Plans - baoquankhu1.vn

Mar 28, 2026

Mar 28, 2026

Nasdaq Moves: Does Jupiter Neurosciences Inc outperform in volatile marketsQuarterly Investment Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Mar 28, 2026

Mar 28, 2026

Growth Recap: How is Mersana Therapeutics Inc managing supply chain issues2026 Market Outlook & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Mar 28, 2026

Mar 28, 2026

Market Moves: What analysts say about Jupiter Neurosciences Inc stockWeekly Trade Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

Centri - TMX Newsfile

Mar 27, 2026